Stroke recovery does not follow one movement pattern, and sedentary profiles may help personalize rehabilitation For a long time, rehabilitation after stroke has been organized around very concrete goals: walking again, rebuilding strength, improving...
Read moreSome HDAC inhibitors may be limited by more than epigenetics, raising new questions about how these cancer drugs really work Few ideas have been as influential in modern oncology as the notion that cancer can be treated not only by killing tumour cel...
Read moreGLP-1 drugs may help the heart beyond weight loss, but the strongest autoimmune evidence still centres on psoriasis Few medication classes have changed the public conversation around obesity and diabetes as much in recent years as GLP-1 receptor agon...
Read moreInfections can worsen diabetes complications, especially in the feet, but the broad headline is not confirmed by the supplied studies When people talk about diabetes complications, the focus usually falls on the heart, kidneys, eyes, and nerves. But...
Read moreA new attack on KRAS is raising hope in pancreatic cancer, but the strongest evidence is still preclinical Few cancer diagnoses carry as much weight as advanced pancreatic cancer. It is often found late, remains difficult to treat, and is still assoc...
Read moreResearchers are uncovering how glioblastoma spreads through the brain — and where it may be possible to slow it down Among brain tumours, few diagnoses are as feared as glioblastoma. It is aggressive, difficult to control, and notorious for returning...
Read moreTORCH infections still pose a serious pregnancy risk — and some of the harm can be prevented Not every pregnancy risk shows up clearly on an ultrasound or announces itself with obvious symptoms. Some of the most serious threats to a baby’s developmen...
Read morePET scans are becoming more important for tracking Alzheimer’s treatment response, but they still cannot tell on their own who will benefit most For years, Alzheimer’s disease was largely managed through symptoms, clinical observation, and slow chang...
Read moreA common deworming drug is emerging as a low-cost brain cancer candidate, but clinical benefit remains unproven Few ideas in oncology attract as much interest as the possibility of repurposing an already familiar, inexpensive, widely available drug f...
Read more
